230 related articles for article (PubMed ID: 26843501)
1. Characteristics of FDA drug recalls: A 30-month analysis.
Hall K; Stewart T; Chang J; Freeman MK
Am J Health Syst Pharm; 2016 Feb; 73(4):235-40. PubMed ID: 26843501
[TBL] [Abstract][Full Text] [Related]
2. Moulds associated with contaminated ocular and injectable drugs: FDA recalls, epidemiology considerations, drug shortages, and aseptic processing.
Ahearn DG; Stulting RD
Med Mycol; 2018 Jun; 56(4):389-394. PubMed ID: 29420758
[TBL] [Abstract][Full Text] [Related]
3. Categorization and comparisons of drug recalls for manufacturers and compounders.
Mattingly AN; Mattingly TJ; Nguyen Phan AL; Negash K
J Am Pharm Assoc (2003); 2022; 62(4):1344-1350. PubMed ID: 35422393
[TBL] [Abstract][Full Text] [Related]
4. Human Medicines Recall Announcements in Saudi Arabia Between 2017 and 2022: An Analysis of Saudi Food and Drug Authority (SFDA) Reports.
Almutairi M; Algabbani A; Alasiri A; Alhomaidan A; Alqahtani AS
Ther Innov Regul Sci; 2024 Jul; 58(4):689-695. PubMed ID: 38546962
[TBL] [Abstract][Full Text] [Related]
5. [Trends in Non-prescription Drug Recalls in Japan].
Yamamoto C; Ishida T; Osawa T; Naito T; Kawakami J
Yakugaku Zasshi; 2016; 136(9):1307-12. PubMed ID: 27592833
[TBL] [Abstract][Full Text] [Related]
6. Blood product recalls in the United States.
McCullough J; Riley E; Lindgren B; Pulkrabek S; Hall R; Riley W
Transfusion; 2014 Sep; 54(9):2276-82. PubMed ID: 24863173
[TBL] [Abstract][Full Text] [Related]
7. A four-year assessment of the characteristics of Rwandan FDA drug recalls.
Bahizi M; Nyirimigabo E; Ntirenganya L; Umuhoza MI; Habyalimana V; Bikorimana G; Ukwishaka J
BMC Public Health; 2024 Jul; 24(1):1784. PubMed ID: 38965502
[TBL] [Abstract][Full Text] [Related]
8. Twenty-Two Years of U.S. Meat and Poultry Product Recalls: Implications for Food Safety and Food Waste.
Gorton A; Stasiewicz MJ
J Food Prot; 2017 Apr; 80(4):674-684. PubMed ID: 28294687
[TBL] [Abstract][Full Text] [Related]
9. FDA Warns of Hidden Prescription Drugs in Dietary Supplements.
Aschenbrenner DS
Am J Nurs; 2019 May; 119(5):22-23. PubMed ID: 31033549
[No Abstract] [Full Text] [Related]
10. Unapproved prescription cough, cold, and allergy drug products: recent US Food and Drug Administration regulatory action on unapproved cough, cold, and allergy medications.
Ostroff C; Lee CE; McMeekin J
Chest; 2011 Aug; 140(2):295-300. PubMed ID: 21813527
[TBL] [Abstract][Full Text] [Related]
11. Critical Analysis of Drug Product Recalls due to Nitrosamine Impurities.
Bharate SS
J Med Chem; 2021 Mar; 64(6):2923-2936. PubMed ID: 33706513
[TBL] [Abstract][Full Text] [Related]
12. Is Nutrient Content and Other Label Information for Prescription Prenatal Supplements Different from Nonprescription Products?
Saldanha LG; Dwyer JT; Andrews KW; Brown LL; Costello RB; Ershow AG; Gusev PA; Hardy CJ; Pehrsson PR
J Acad Nutr Diet; 2017 Sep; 117(9):1429-1436. PubMed ID: 28571654
[TBL] [Abstract][Full Text] [Related]
13. Quality of medicines in Canada: a retrospective review of risk communication documents (2005-2013).
Almuzaini T; Sammons H; Choonara I
BMJ Open; 2014 Oct; 4(10):e006088. PubMed ID: 25361839
[TBL] [Abstract][Full Text] [Related]
14. Research: Evaluation of Orthopedic Hip Device Recalls by the FDA from 2007 to 2017.
Peters W; Pellerin C; Janney C
Biomed Instrum Technol; 2020 Nov; 54(6):418-426. PubMed ID: 33339030
[TBL] [Abstract][Full Text] [Related]
15. Blood component recalls in the United States.
Ramsey G; Sherman LA
Transfusion; 1999 May; 39(5):473-8. PubMed ID: 10335996
[TBL] [Abstract][Full Text] [Related]
16. A retrospective regulatory analysis of FDA recalls carried out by pharmaceutical companies from 2012 to 2023.
Patel R; Vhora A; Jain D; Patel R; Khunt D; Patel R; Dyawanapelly S; Junnuthula V
Drug Discov Today; 2024 Jun; 29(6):103993. PubMed ID: 38670257
[TBL] [Abstract][Full Text] [Related]
17. Reflections of the Angiotensin Receptor Blocker Recall by the FDA and Repercussions on Healthcare.
Gillette M; Taylor A; Butulija D; Kadiyala H; Jneid H
Cardiovasc Drugs Ther; 2020 Aug; 34(4):579-584. PubMed ID: 32318933
[TBL] [Abstract][Full Text] [Related]
18. Association Between Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510(k) Clearance.
Everhart AO; Sen S; Stern AD; Zhu Y; Karaca-Mandic P
JAMA; 2023 Jan; 329(2):144-156. PubMed ID: 36625811
[TBL] [Abstract][Full Text] [Related]
19. Error Types and Associations of Clinically Significant Events Within Food and Drug Administration Recalls of Linear Accelerators and Related Products.
Jairam V; Lincoln HM; Brown DW; Park HS; Evans SB
Pract Radiat Oncol; 2020; 10(1):e8-e15. PubMed ID: 31408733
[TBL] [Abstract][Full Text] [Related]
20. Recalls of foods containing undeclared allergens reported to the US Food and Drug Administration, fiscal year 1999.
Vierk K; Falci K; Wolyniak C; Klontz KC
J Allergy Clin Immunol; 2002 Jun; 109(6):1022-6. PubMed ID: 12063535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
